NCT01270984 - Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Chronic Myeloid LeukemiaGastrointestinal Stromal Tumors

Interventions

DRUG

Luckyvec 400mg film coated tablet

•400mg/tablet, PO, 1 tablet once daily for Period I \& II D1(crossover)

DRUG

Glivec 100mg film coated tablet

•100mg/tablet, PO, 4 tablets once daily for Period I \& II D1(crossover)

Trial Locations (1)

The Korea University Anam Hospital, Seoul